Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
Comparison · Analytics
DoseFinding vs OpenCTI
A side-by-side editorial comparison of DoseFinding and OpenCTI — release velocity, themes, recent moves, and the top alternatives to consider.
DoseFinding vs OpenCTI: at a glance
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
What is OpenCTI?
OpenCTI spends a release unblocking queues and hardening upserts
7.260817.0 is a fix release. The most consequential item is malformed STIX messages nacking forever and blocking worker queues indefinitely — a stall in the ingestion path rather than a display bug. Alongside it: upsert clearing an existing createdBy when incoming confidence is higher, draft upserts crashing on existing attack patterns, OTP handling in the stream middleware, and case template relation authorization. Score fields were added to threat actor groups, intrusion sets and malware.
DoseFinding vs OpenCTI: editorial side-by-side
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
OpenCTI
6.3ANALYTICS
OpenCTI spends a release unblocking queues and hardening upserts
◆ Current state
7.260817.0 is a fix release. The most consequential item is malformed STIX messages nacking forever and blocking worker queues indefinitely — a stall in the ingestion path rather than a display bug. Alongside it: upsert clearing an existing createdBy when incoming confidence is higher, draft upserts crashing on existing attack patterns, OTP handling in the stream middleware, and case template relation authorization. Score fields were added to threat actor groups, intrusion sets and malware.
◆ Where it's heading
The platform's feature energy went into the connector catalog and integrations rework in July, and the releases since have been consolidating: mass operations on relation times, shareable saved searches, and now a pass over ingestion robustness. Adding score to more entity types continues the slow enrichment of the data model that runs underneath the feature work.
◆ Prediction
Given score arriving on three entity types in one release, expect it to keep spreading across the data model, and the queue-blocking class of bug to draw more worker-side hardening.
Alternatives to DoseFinding and OpenCTI
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or OpenCTI.
silx
silx settles into maintenance a release after its PySide6 migration
Plotly
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread
aniread stops asking you to know which tracker wrote the file
Rho
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
See all DoseFinding alternatives → · See all OpenCTI alternatives →
Recent activity from DoseFinding and OpenCTI
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 1d agoOpenCTIMalformed STIX no longer blocks worker queues indefinitely
- 4d agoOpenCTILTS branch gets the security backport: access-scoped streams, dependency sweep
- 7d agoOpenCTIMass operations can now edit relation start and stop times
- 11d agoOpenCTISaved searches and dashboard filters become shareable and reusable
- 15d agoOpenCTIData sanity operations can be stopped mid-run
- 20d agoOpenCTIIntegrations experience reworked around the new catalog, plus draft approval workflows
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
Frequently asked questions
What is the difference between DoseFinding and OpenCTI?
They serve adjacent needs but don't currently overlap on shipped themes. OpenCTI is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DoseFinding better than OpenCTI?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. OpenCTI is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
What are the best alternatives to OpenCTI?
Top OpenCTI alternatives in Analytics are ranked by recent ship velocity. Browse the "OpenCTI alternatives" section above for the current picks, or visit /alternatives/opencti for the full list with editorial commentary on each.